Publication Cover
Expert Review of Precision Medicine and Drug Development
Personalized medicine in drug development and clinical practice
Volume 9, 2024 - Issue 1
362
Views
0
CrossRef citations to date
0
Altmetric
Review

Advances in the field of developing biomarkers for re-irradiation: a how-to guide to small, powerful data sets and artificial intelligence

, , , , &
Pages 3-16 | Received 20 Jul 2023, Accepted 28 Feb 2024, Published online: 11 Mar 2024

Figures & data

Figure 1. Publications on re-RT based on the Web of Science search for the terms “re-irradiation” and “reirradiation” [Citation1].

Figure 1. Publications on re-RT based on the Web of Science search for the terms “re-irradiation” and “reirradiation” [Citation1].

Figure 2. Sankey Chart evaluating the publication landscape in re-RT [Citation1]. Head and neck and glioma feature most prominently in re-RT publications, while other cancer sites benefit from fewer articles and more reviews addressing re-RT. Linkages between technical approaches and their implementation in various oncologic sites are increasing but are concentrated in some oncologic sites and are relatively scarce in others, such as bladder cancer.

Figure 2. Sankey Chart evaluating the publication landscape in re-RT [Citation1]. Head and neck and glioma feature most prominently in re-RT publications, while other cancer sites benefit from fewer articles and more reviews addressing re-RT. Linkages between technical approaches and their implementation in various oncologic sites are increasing but are concentrated in some oncologic sites and are relatively scarce in others, such as bladder cancer.

Figure 3. Diagram of the literature review process.

Figure 3. Diagram of the literature review process.

Table 1. Existing re-irradiation datasets based on literature search. Glioma and nasopharyngeal cancer are the most common tumor sites represented.

Table 2. Strategies employed to approach small data sets.

Figure 4. Strategies to handle limited data scenarios for machine learning problems.

Figure 4. Strategies to handle limited data scenarios for machine learning problems.

Figure 5. The blessing of dimensionality in small data sets [Citation77–79]. In small data sets, the wide dimensionality of data, when available, can be leveraged using machine learning and deep learning to classify patients based on clinical, imaging, and molecular characteristics to arrive at features that can be employed for prediction and subsequently retraining. Conclusions can be employed to optimize data acquisition (e.g. on study protocols and in clinic on the standard of care, e.g. post-re-RT imaging fusion and analysis for response), as well as data curation (e.g. dose to organs at risk in the RT field).

Figure 5. The blessing of dimensionality in small data sets [Citation77–79]. In small data sets, the wide dimensionality of data, when available, can be leveraged using machine learning and deep learning to classify patients based on clinical, imaging, and molecular characteristics to arrive at features that can be employed for prediction and subsequently retraining. Conclusions can be employed to optimize data acquisition (e.g. on study protocols and in clinic on the standard of care, e.g. post-re-RT imaging fusion and analysis for response), as well as data curation (e.g. dose to organs at risk in the RT field).